Skip to main content
. 2021 Feb 22;53(2):2761. doi: 10.2340/16501977-2801

Table II.

Standardized measures of treatment effectiveness for areas relevant to goal domains

Measure Baseline Mean (95% CI) Change Mean (95% CI) p-value vs baseline
Pain score (range 0-10) n = 346 n =345 <0.001
6.7 (6.5, 6.9) -2.4 (-2.6, -2.2)
Associated Reaction Rating Scale (ARRS) (range 0-12) n = 207 n =201 <0.001
7.4 (7.0, 7.7) -1.4 (-1.6, -1.1)
Arm Activity (ArmA) scores; Passive function (range 0-28) n = 435 n = 429 <0.001
14.1 (13.6, 14.6) -2.9 (-3.3, -2.6)
Arm Activity (ArmA) scores; Active function (range 0-52) n = 216 n =207 <0.001
39.8 (38.4, 41.2) -3.2 (-4.3, -2.2)
Functional Ambulation Category (FAC) scores n = 32 n =30 0.071
3.7 (3.24; 4.13) 0.3 (-0.1, 0.7)
ULS-NIS impaired mobility of joints* n = 335 n =335
 Proximal (shoulder and elbow) 1.8 (1.7, 2.0) -0.2 (-0.3, -0.1) <0.0001
 Distal (wrist and hand) 2.3 (2.1, 2.5) -0.4 (-0. 5, -0.2) <0.0001
*

Paired t-test performed post-hoc. Scores are presented as the arithmetic mean of post-baseline scores across all evaluation cycles. Depending on in which areas goals were set at different visits, not all patients had both baseline and post-baseline assessments.

ULS-NIS: Upper Limb Spasticity adapted Neurological Impairment Scale.